BioDlink International Company Limited
Status: Publicly traded
Direct answer
BioDlink International Company Limited is publicly traded on HKSE under the ticker 1875.HK.
BioDlink International Co., Ltd. operates as a clinical-stage biopharmaceutical firm, dedicating its resources to the development and future commercialization of novel oncology drugs and therapeutic solutions. Its pipeline features several key product candidates, including TAB008, TOZ309, TAA013, TAE020, TAB 014, and TAC020. The company was founded on December 4, 2009, and its primary base of operations is situated...
Can you invest in BioDlink International Company Limited?
Yes. BioDlink International Company Limited trades publicly on HKSE as 1875.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for BioDlink International Company Limited
Detailed equity research is provided by MarketSnap.